179 related articles for article (PubMed ID: 9067778)
1. Development of differential cytotoxic compounds containing nitrosourea and benzothiazine nucleus.
Nyati MK; Rai D; Gupta RR; Dev PK
In Vivo; 1997; 11(1):95-9. PubMed ID: 9067778
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of ethylnitrosoureas of substituted naphthalimides as anticancer compounds.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Sharma M; Qazi GN; Sanyal U
Acta Pol Pharm; 2007; 64(1):27-33. PubMed ID: 17665847
[TBL] [Abstract][Full Text] [Related]
3. Antitumor 2-(aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)- hydrazines.
Shyam K; Penketh PG; Loomis RH; Rose WC; Sartorelli AC
J Med Chem; 1996 Feb; 39(3):796-801. PubMed ID: 8576923
[TBL] [Abstract][Full Text] [Related]
4. [Effect of N-methyl-N-nitrosourea on the synthesis and processing of RNA in Ehrlich ascitic carcinoma and leukemia L1210 cells].
Dederer LIu; Kukushkina GV; Gorbacheva LB
Dokl Akad Nauk SSSR; 1975; 221(3):736-9. PubMed ID: 1120464
[No Abstract] [Full Text] [Related]
5. Pt-ATP as an antineoplastic agent in an experimental mice model system.
Pal S; Mukherjea K; Bhattacharya R; Maity P
J Exp Clin Cancer Res; 1997 Sep; 16(3):255-60. PubMed ID: 9387898
[TBL] [Abstract][Full Text] [Related]
6. Comparison of new nitrosoureas esters with modified steroidal nucleus for cytogenetic and antineoplastic activity.
Hussein A; Mioglou-Kalouptsi E; Papageorgiou A; Karapidaki I; Iakovidou-Kritsi Z; Lialiaris T; Xrysogelou E; Camoutsis C; Mourelatos D
In Vivo; 2007; 21(2):389-95. PubMed ID: 17436593
[TBL] [Abstract][Full Text] [Related]
7. Nucleoside analogues. 13. The effect on anti-tumour activity of varying the uracil 5-substituent and the point of attachment (N1 or N3) of the uracil moiety in seco-nucleoside nitrosoureas.
Bibby MC; Double JA; McCormick JE; McElhinney RS; Radacic M; Pratesi G; Dumont P
Anticancer Drug Des; 1993 Apr; 8(2):115-28. PubMed ID: 8494602
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of dimethoxydop-NU as a novel anti-tumor agent.
Mukherjee A; Dutta S; Sanyal U
J Exp Clin Cancer Res; 2007 Dec; 26(4):489-97. PubMed ID: 18365543
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of 2-chloroethylnitrosoureas of substituted naphthalimides as mixed-function anticancer compounds.
Samanta S; Pain A; Dutta S; Sanyal U
Acta Pol Pharm; 2001; 58(5):351-6. PubMed ID: 11876442
[TBL] [Abstract][Full Text] [Related]
12. Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents.
El-Far M; Elmegeed GA; Eskander EF; Rady HM; Tantawy MA
Eur J Med Chem; 2009 Oct; 44(10):3936-46. PubMed ID: 19447526
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo.
Cebović T; Spasić S; Popović M
Phytother Res; 2008 Aug; 22(8):1097-103. PubMed ID: 18570233
[TBL] [Abstract][Full Text] [Related]
14. [The dose-dependent cytogenetic and growth-inhibiting effects of a new antitumor preparation from the nitrosourea group].
Fomina MM; Dzhamanbaev ZhA; Ostrovskaia LA
Izv Akad Nauk SSSR Biol; 1991; (3):436-44. PubMed ID: 1955617
[TBL] [Abstract][Full Text] [Related]
15. [Antitumor effects of organic silicone compounds (IV). Antitumor effects of SDK-50 and SDK-47].
Toyoshima S; Fukushima K; Sakurai T; Sugimoto Y; Sato H; Taguchi H
Gan To Kagaku Ryoho; 1982 Feb; 9(2):225-9. PubMed ID: 7184399
[TBL] [Abstract][Full Text] [Related]
16. The influence of three newly synthesized pyrimidine-containing compounds on micronucleus induction and tumor growth.
Nersesyan A; Muradyan R; Arsenyan F
J BUON; 2007; 12(4):521-7. PubMed ID: 18067211
[TBL] [Abstract][Full Text] [Related]
17. Effect of lysolecithin and analogs on mouse ascites tumors.
Tarnowski GS; Mountain IM; Stock CC; Munder PG; Weltzien HU; Westphal O
Cancer Res; 1978 Feb; 38(2):339-44. PubMed ID: 620405
[No Abstract] [Full Text] [Related]
18. [Toxicity and antitumoral activity of two new complex compounds of rhenium].
Natorkhin MI; Stukov AN; Filov VA
Vopr Onkol; 2002; 48(1):61-2. PubMed ID: 12101569
[TBL] [Abstract][Full Text] [Related]
19. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs.
El-Shafei A; Fadda AA; Khalil AM; Ameen TA; Badria FA
Bioorg Med Chem; 2009 Jul; 17(14):5096-105. PubMed ID: 19527933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
